Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 25.95M P/E - EPS this Y - Ern Qtrly Grth -
Income -20.13M Forward P/E -1.51 EPS next Y - 50D Avg Chg 44.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book 10.69 EPS next 5Y - 52W High Chg -84.00%
Recommedations 2.00 Quick Ratio 0.48 Shares Outstanding 12.14M 52W Low Chg 83.00%
Insider Own 37.61% ROA -172.83% Shares Float 12.75B Beta 0.95
Inst Own 1.53% ROE - Shares Shorted/Prior 40.74K/29.18K Price 0.26
Gross Margin - Profit Margin - Avg. Volume 559,770 Target Price -
Oper. Margin - Earnings Date Aug 19 Volume 916,728 Change -4.04%
About Akari Therapeutics Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.

Akari Therapeutics Plc News
12/18/24 Akari Therapeutics Announces Key Leadership Appointments
12/16/24 Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
11/19/24 Akari Therapeutics Regains Full Nasdaq Compliance
11/15/24 This Akari Therapeutics Insider Increased Their Holding By 69% Last Year
11/14/24 Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
11/08/24 Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
10/15/24 Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
09/17/24 Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
08/19/24 Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
08/19/24 Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy
06/05/24 Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
06/04/24 Akari Therapeutics Secures $7.6 Million in Upsized Financing Round
05/16/24 Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
05/01/24 Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
05/01/24 Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
04/15/24 Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
04/01/24 Akari Therapeutics Insider Ups Holding By 69% During Year
04/01/24 Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
03/05/24 Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
01/02/24 Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
AKTX Chatroom

User Image MTN Posted - 1 day ago

$AKTX seems the selling is tapering off. We'll see where it goes from here.

User Image MTN Posted - 2 days ago

$AKTX can't tell when the selling ends. Hopefully soon.

User Image MTN Posted - 5 days ago

$AKTX still seeing selling from the shares that were given to the SPAC firm at Peak. Again, hoping Dr Patel is ready to roll up is sleeves and get to work.

User Image StockTwitsNinja Posted - 6 days ago

$AKTX I wonder why it is not reacting to this release today : https://investor.akaritx.com/news-releases/news-release-details/akari-therapeutics-announces-key-leadership-appointments

User Image topstockalerts Posted - 1 week ago

Pre Market Top Gainers PT2 $MSS $CAMP $AKTX $EHTH $SIDU

User Image Bart69 Posted - 1 week ago

$AKTX Hmmm. Interesting Bid jump.

User Image MelttheMandMs Posted - 1 week ago

$AKTX Quick internet search was able to divulge that Hombeck had racked up over $68k in credit card debt. This is extremely disqualifying for a financial position in a company, much less a CFO position at a public company. Any shareholder with a pre-frontal cortex should be demanding this appointment is reversed.

User Image MelttheMandMs Posted - 1 week ago

$AKTX brilliant move

User Image stockscan Posted - 1 week ago

$AKTX Torsten Hombeck is hired back as CFO. https://www.globenewswire.com/news-release/2024/12/16/2997598/0/en/Akari-Therapeutics-Appoints-Torsten-Hombeck-Ph-D-as-Chief-Financial-Officer.html

User Image MTN Posted - 1 week ago

$AKTX the only thing keeping me in this is my stubbornness, the promising pipeline, and the new management. That's it. Management more than anything at this point. I hope they are genuine.

User Image Nike975 Posted - 1 week ago

$AKTX Please give a call to management if you can

User Image jennybaby Posted - 1 week ago

$AKTX not going to lie. This is simply inexplicable. After I spoke with Dr. Patel, I was confident that he is the right person for the job and has a lot of personal skin in the game. However, I can’t keep money idle. So I sold most of my position @ 1.30 and kept what’s in my IRA. I will revisit and build back once I see a bit clearer.

User Image Htsone Posted - 1 week ago

$AKTX Wonder what happened to Mr. Potato Head? King of tuber pumpers.

User Image Nike975 Posted - 1 week ago

$AKTX Lost all my hope here ! Not going to average down . Made a mistake not selling at 4$

User Image hany1166 Posted - 1 week ago

$AKTX under a buck now they do a new offering and then split and then all new bag holders and then wash and start all over shit ceo shit company they should all fo to hell

User Image coachmc Posted - 1 week ago

$AKTX where did nick go 😆

User Image Nike975 Posted - 1 week ago

$AKTX Any hope left here ? Down toooooo much

User Image esj11 Posted - 1 week ago

@Wellthen yes. he would like you to buy $AKTX

User Image Bart69 Posted - 2 weeks ago

$AKTX Added more under a buck. Will keep doing so. Games being played today with stocks across the board.

User Image StockTwitsNinja Posted - 2 weeks ago

$AKTX

User Image OttoDydakte Posted - 2 weeks ago

$AKTX 1.68 coming back or stop loss?

User Image MTN Posted - 2 weeks ago

$AKTX selling looks like it is still not done. Let's see where this goes this week.

User Image jennybaby Posted - 2 weeks ago

$AKTX it looks like we finally have a golden cross on the daily. Let’s hope we begin to steadily recover from here on out. 👏👏

User Image isaacwilliams33 Posted - 3 weeks ago

$AKTX [email protected]

User Image MelttheMandMs Posted - 11/27/24

$AKTX Still on their main page under pipeline. 2024 is basically over. They came out in July 2024 and said IND wasn’t happening until “2025”. Absolute dysfunction…

User Image isaacwilliams33 Posted - 11/26/24

$AKTX

User Image jennybaby Posted - 11/26/24

$AKTX I hope we capitulated and hit bottom. I added back up to my 25k shares size that I wanted to build back up to. It’s hard taking profits when you expect share appreciation but it allows you to have some cash for these times. As painful as it is, here we are. And for my technical savants, the MACD is about to cross over on the 4hr chart, still lagging a bit on the daily.

User Image Nick1971 Posted - 11/26/24

$AKTX new presentation is out. Crazy undervalued stock https://investor.akaritx.com/static-files/d0829da9-d8de-420a-9173-3ad62e1fdb86

User Image 718Pigeon Posted - 11/26/24

$AKTX NICE, 10 K down. Good think i already made it back somewhere else.

User Image 718Pigeon Posted - 11/26/24

$AKTX here we go, we are a penny stock now.